Literature DB >> 16949805

Further characterization of theobroma oil-beeswax admixtures as lipid matrices for improved drug delivery systems.

A A Attama1, B C Schicke, C C Müller-Goymann.   

Abstract

There is an increasing interest in lipid based drug delivery systems due to factors such as better characterization of lipidic excipients and formulation versatility and the choice of different drug delivery systems. It is important to know the thermal characteristics, crystal habit, texture, and appearance of a new lipid matrix when determining its suitability for use in certain pharmaceutical application. It is line with this that this research was embarked upon to characterize mixtures of beeswax and theobroma oil with a view to applying their admixtures in drug delivery systems such as solid lipid nanoparticles and nanostructured lipid carriers. Admixtures of theobroma oil and beeswax were prepared to contain 25% w/w, 50% w/w, and 75% w/w of theobroma oil. The admixtures were analyzed by differential scanning calorimetry (DSC), small angle X-ray diffraction (SAXD), wide angle X-ray diffraction (WAXD), and isothermal heat conduction microcalorimetry (IMC). The melting behavior and microstructures of the lipid admixtures were monitored by polarized light microscopy (PLM). Transmission electron microscopy (TEM) was used to study the internal structures of the lipid bases. DSC traces indicated that the higher melting peaks were roughly constant for the different admixtures, but lower melting peaks significantly increased (p < 0.05). The admixture containing 25% w/w of theobroma oil possessed highest crystallinity index of 95.6%. WAXD studies indicated different reflections for the different lipid matrices. However, new interferences were detected for all the lipid matrix admixtures between 2theta = 22.0 degrees and 2theta = 25.0 degrees. The lipid matrices containing 50% w/w and 25% w/w of theobroma oil showed absence of the weak reflection characteristic of pure theobroma oil, while there was disappearance of the strong intensity reflection of beeswax in all the lipid matrix admixtures at all stages of the study. PLM micrographs revealed differences with regard to the thermal and optical behaviors depending on the composition of the matrix. The lipid matrix consisting of 75% w/w of theobroma oil showed a spherulite texture after 4 weeks of isothermal storage. Crystallization exotherms of lipid matrices containing 50% w/w and 25% w/w of theobroma oil showed change in modification after 30 min with the latter having a greater time-dependent crystallization. Generally, low non-integral Avrami exponents and growth rate constants were obtained for all the lipid matrices, with the admixture containing 25% w/w theobroma oil having the lowest Avrami exponent and growth rate constant. Based on the results obtained, admixtures containing 50% w/w and 75% w/w of theobroma oil could be applied in the formulation of solid lipid nanoparticles and nanostructured lipid carriers as these lipid matrices possessed crystal characteristics that favour such drug delivery systems.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949805     DOI: 10.1016/j.ejpb.2006.06.010

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  10 in total

1.  Lipid effects on expulsion rate of amphotericin B from solid lipid nanoparticles.

Authors:  See Wei Tan; Nashiru Billa
Journal:  AAPS PharmSciTech       Date:  2013-12-07       Impact factor: 3.246

2.  Improved antimalarial activity of caprol-based nanostructured lipid carriers encapsulating artemether-lumefantrine for oral administration.

Authors:  Paul Achile Akpa; Joseph Abuchi Ugwuoke; Anthony Amaechi Attama; Chinenye Nnenna Ugwu; Ezinwanne Nneoma Ezeibe; Mumuni Audu Momoh; Adaeze Chidiebere Echezona; Franklin Chimaobi Kenechukwu
Journal:  Afr Health Sci       Date:  2020-12       Impact factor: 0.927

3.  Fabrication of Alginate-Based O/W Nanoemulsions for Transdermal Drug Delivery of Lidocaine: Influence of the Oil Phase and Surfactant.

Authors:  Omar Sarheed; Manar Dibi; Kanteti V R N S Ramesh; Markus Drechsler
Journal:  Molecules       Date:  2021-04-27       Impact factor: 4.411

4.  Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide.

Authors:  John Youshia; Amany O Kamel; Abdelhameed El Shamy; Samar Mansour
Journal:  Int J Nanomedicine       Date:  2012-05-17

5.  Formulation, Characterisation, and in Vitro Skin Diffusion of Nanostructured Lipid Carriers for Deoxyarbutin Compared to a Nanoemulsion and Conventional Cream.

Authors:  Rendra P Tofani; Yeyet C Sumirtapura; Sasanti T Darijanto
Journal:  Sci Pharm       Date:  2016-07-20

6.  Preparation and Statistical Modeling of Solid Lipid Nanoparticles of Dimethyl Fumarate for Better Management of Multiple Sclerosis.

Authors:  Smriti Ojha; Babita Kumar
Journal:  Adv Pharm Bull       Date:  2018-06-19

7.  Nanocarriers From Natural Lipids With In Vitro Activity Against Campylobacter jejuni.

Authors:  Lígia Nunes de Morais Ribeiro; Eneida de Paula; Daise Aparecida Rossi; Flávia Alves Martins; Roberta Torres de Melo; Guilherme Paz Monteiro; Márcia Cristina Breitkreitz; Luiz Ricardo Goulart; Belchiolina Beatriz Fonseca
Journal:  Front Cell Infect Microbiol       Date:  2021-01-08       Impact factor: 5.293

8.  Alendronate Sodium as Enteric Coated Solid Lipid Nanoparticles; Preparation, Optimization, and In Vivo Evaluation to Enhance Its Oral Bioavailability.

Authors:  Khaled Mohamed Hosny
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

9.  Physicochemical and Antimicrobial Characterization of Beeswax-Starch Food-Grade Nanoemulsions Incorporating Natural Antimicrobials.

Authors:  Teresita Arredondo-Ochoa; Blanca E García-Almendárez; Monserrat Escamilla-García; Olga Martín-Belloso; Giovanna Rossi-Márquez; Luis Medina-Torres; Carlos Regalado-González
Journal:  Int J Mol Sci       Date:  2017-12-15       Impact factor: 5.923

10.  Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.

Authors:  Marzia Cirri; Lavinia Maestrini; Francesca Maestrelli; Natascia Mennini; Paola Mura; Carla Ghelardini; Lorenzo Di Cesare Mannelli
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.